Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity [Internet]
Kawakami, Y., Watanabe, Y., Mazuka, M., Yagi, N., Sawazaki, A., Koganei, M., Natsume, M., Kuriki, K., Morimoto, T., Asai, T., & Arai, H
Moreover, managing diabetes during cancer treatment is a crucial aspect often overshadowed by the primary focus on cancer therapies
Only one in every 5,000 medicines tested for the potential to treat illness is eventually approved for patient use, and studies estimate that developing a new drug takes 10 to 15 years and costs more than $1.3B
Improvements in cardiometabolic risk factors by weight reduction: a post hoc analysis of adults with obesity randomly assigned to tirzepatide